Evidence map›Paper›PMID 22566797›Full record

ArticleFrontiers in immunology2011

A CD25⁻ positive population of activated B1 cells expresses LIFR and responds to LIF.

Joseph R Tumang, Nichol E Holodick, Teresa C Vizconde, Hiroaki Kaku, Rubén Francés, Thomas L Rothstein

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. B1 Cells for Life.Immunological reviews · 2026
    Review
  2. Article
  3. IgMJournal of leukocyte biology · 2022
    Article
  4. Sex Influences Age-Related Changes in Natural Antibodies and CD5Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Defining Natural Antibodies.Frontiers in immunology · 2017
    Article
  9. CD25Frontiers in immunology · 2017
    Article
  10. Article
  11. New insights into heterogeneity of peritoneal B-1a cells.Annals of the New York Academy of Sciences · 2015
    Review
  12. Article
  13. Human B-1 cells take the stage.Annals of the New York Academy of Sciences · 2013
    Review
  14. Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joseph R TumangImmunobiology Laboratory, Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research Manhasset, NY, USA.
Nichol E Holodick
Teresa C Vizconde
Hiroaki Kaku
Rubén Francés
Thomas L Rothstein
Feinstein Institute for Medical Research · US

Funding

PHORBOL ESTER RESPONSIVE B LYMPHOCYTESR01AI029690 · NIAID · WESTERN MICHIGAN UNIV SCHOOL OF MEDICINE · PI ROTHSTEIN, THOMAS L · 1990 to 2019
$6.9M
REGULATION AND FUNCTION OF CYCLIN D3 IN B CELL SUBSETSP01AI060896 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI ROTHSTEIN, THOMAS L · 2004 to 2008
$4.5M
Aberrant Signaling in B-1 CellsR56AI029690 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI ROTHSTEIN, THOMAS L · 2008 to 2008
$414k
NIAID NIH HHS P01 AI060896NIAID NIH HHS R01 AI029690NIAID NIH HHS R56 AI029690
6 · The paper itself

Abstract

B1 B cells defend against infectious microorganisms by spontaneous secretion of broadly reactive "natural" immunoglobulin that appears in the absence of immunization. Among many distinguishing characteristics, B1 B cells display evidence of activation that includes phosphorylated STAT3. In order to identify the origin of pSTAT3 we examined interleukin-2 receptor (IL-2R) expression on B1 cells. We found that some (about 1/5) B1a cells express the IL-2R α chain, CD25. Although lacking CD122 and unresponsive to IL-2, B1a cells marked by CD25 express increased levels of activated signaling intermediates, interruption of which results in diminished CD25. Further, CD25⁺ B1a cells contain most of the pSTAT3 found in the B1a population as a whole. Moreover, CD25⁺ B1a cells express leukemia inhibitory factor receptor (LIFR), and respond to LIF by upregulating pSTAT3. Together, these results define a new subset of B1a cells that is marked by activation-dependent CD25 expression, expresses substantial amounts of activated STAT3, and contains a functional LIFR.

Indexed as

B1 cellsCD25LIF receptorsignaling

Identifiers

PMID22566797
PMCPMC3342026
OpenAlexW2135460492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.